Due to the size of the Brazilian market for aesthetic and therapeutic products, Pharmaesthetics Group S.A. decided to build its first laboratory for the manufacture of health products, medicines and biological drugs in the city of Pinhais, state of Paraná, Brazil.
Brazil is one of the three largest markets for the aesthetic products industry. That's why, with cutting-edge products and visionary leadership, the company decided to open its first production site for the latest generation of cross-linked hyaluronic acid and botulinum toxin type A in Brazil.
